To include your compound in the COVID-19 Resource Center, submit it here.

MedPAC proposes including biosimilars in Part D gap coverage

At a public meeting on Nov. 3, the Medicare Payment Advisory Commission proposed including biosimilars in the Medicare Part D

Read the full 203 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE